These correlations further reflect the relationship of MEIS1 expression and patient outcome in all AML patients (excluding t(15;17)) (p = 0.0039), CN-AML (p = 0.0036), NPM1-wildtype CN-AML (p = 0.00046) NPM1-mutated CN-AML (p = 0.072) and NPM1-mutated/FLT3-wildtype CN-AML (p = 0.017) (Supplementary Fig. S8). Here, FLT3 is linked to acute myeloid leukemia.